pubmed-article:17972531 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17972531 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
pubmed-article:17972531 | lifeskim:mentions | umls-concept:C0302600 | lld:lifeskim |
pubmed-article:17972531 | lifeskim:mentions | umls-concept:C0194810 | lld:lifeskim |
pubmed-article:17972531 | lifeskim:mentions | umls-concept:C0034786 | lld:lifeskim |
pubmed-article:17972531 | lifeskim:mentions | umls-concept:C0449438 | lld:lifeskim |
pubmed-article:17972531 | lifeskim:mentions | umls-concept:C1709218 | lld:lifeskim |
pubmed-article:17972531 | lifeskim:mentions | umls-concept:C0231174 | lld:lifeskim |
pubmed-article:17972531 | lifeskim:mentions | umls-concept:C1707520 | lld:lifeskim |
pubmed-article:17972531 | lifeskim:mentions | umls-concept:C0392752 | lld:lifeskim |
pubmed-article:17972531 | pubmed:issue | 5B | lld:pubmed |
pubmed-article:17972531 | pubmed:dateCreated | 2007-11-1 | lld:pubmed |
pubmed-article:17972531 | pubmed:abstractText | The aim of this study was to elucidate the prognostic value of the immunohistochemical detection of the androgen receptor (AR) status, the chromogranin A assessment of neuroendocrine differentiation (NED) and the CD34 assessment of microvessel density (MVD) with time-to-biochemical failure among surgically treated patients with clinically localized prostate cancer. Patients and | lld:pubmed |
pubmed-article:17972531 | pubmed:language | eng | lld:pubmed |
pubmed-article:17972531 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17972531 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17972531 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17972531 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17972531 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17972531 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17972531 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17972531 | pubmed:issn | 0250-7005 | lld:pubmed |
pubmed-article:17972531 | pubmed:author | pubmed-author:KoutsilierisM... | lld:pubmed |
pubmed-article:17972531 | pubmed:author | pubmed-author:ScorilasAndre... | lld:pubmed |
pubmed-article:17972531 | pubmed:author | pubmed-author:PetrakiConsta... | lld:pubmed |
pubmed-article:17972531 | pubmed:author | pubmed-author:HalapasAntoni... | lld:pubmed |
pubmed-article:17972531 | pubmed:author | pubmed-author:KanellisGeorg... | lld:pubmed |
pubmed-article:17972531 | pubmed:author | pubmed-author:MalovrouvasDi... | lld:pubmed |
pubmed-article:17972531 | pubmed:author | pubmed-author:StefanakisSte... | lld:pubmed |
pubmed-article:17972531 | pubmed:author | pubmed-author:RevelosKyriak... | lld:pubmed |
pubmed-article:17972531 | pubmed:author | pubmed-author:Alevizopoulos... | lld:pubmed |
pubmed-article:17972531 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17972531 | pubmed:volume | 27 | lld:pubmed |
pubmed-article:17972531 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17972531 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17972531 | pubmed:pagination | 3651-60 | lld:pubmed |
pubmed-article:17972531 | pubmed:meshHeading | pubmed-meshheading:17972531... | lld:pubmed |
pubmed-article:17972531 | pubmed:meshHeading | pubmed-meshheading:17972531... | lld:pubmed |
pubmed-article:17972531 | pubmed:meshHeading | pubmed-meshheading:17972531... | lld:pubmed |
pubmed-article:17972531 | pubmed:meshHeading | pubmed-meshheading:17972531... | lld:pubmed |
pubmed-article:17972531 | pubmed:meshHeading | pubmed-meshheading:17972531... | lld:pubmed |
pubmed-article:17972531 | pubmed:meshHeading | pubmed-meshheading:17972531... | lld:pubmed |
pubmed-article:17972531 | pubmed:meshHeading | pubmed-meshheading:17972531... | lld:pubmed |
pubmed-article:17972531 | pubmed:meshHeading | pubmed-meshheading:17972531... | lld:pubmed |
pubmed-article:17972531 | pubmed:meshHeading | pubmed-meshheading:17972531... | lld:pubmed |
pubmed-article:17972531 | pubmed:meshHeading | pubmed-meshheading:17972531... | lld:pubmed |
pubmed-article:17972531 | pubmed:meshHeading | pubmed-meshheading:17972531... | lld:pubmed |
pubmed-article:17972531 | pubmed:meshHeading | pubmed-meshheading:17972531... | lld:pubmed |
pubmed-article:17972531 | pubmed:meshHeading | pubmed-meshheading:17972531... | lld:pubmed |
pubmed-article:17972531 | pubmed:meshHeading | pubmed-meshheading:17972531... | lld:pubmed |
pubmed-article:17972531 | pubmed:meshHeading | pubmed-meshheading:17972531... | lld:pubmed |
pubmed-article:17972531 | pubmed:meshHeading | pubmed-meshheading:17972531... | lld:pubmed |
pubmed-article:17972531 | pubmed:meshHeading | pubmed-meshheading:17972531... | lld:pubmed |
pubmed-article:17972531 | pubmed:articleTitle | Correlation of androgen receptor status, neuroendocrine differentiation and angiogenesis with time-to-biochemical failure after radical prostatectomy in clinically localized prostate cancer. | lld:pubmed |
pubmed-article:17972531 | pubmed:affiliation | Department of Pathology, Evangelismos Hospital, Athens, Greece. | lld:pubmed |
pubmed-article:17972531 | pubmed:publicationType | Journal Article | lld:pubmed |
entrez-gene:367 | entrezgene:pubmed | pubmed-article:17972531 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:17972531 | lld:entrezgene |
lhgdn:association:33895 | lhgdn:found_in | pubmed-article:17972531 | lld:lhgdn |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17972531 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17972531 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17972531 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17972531 | lld:pubmed |